This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent. Top assignee: Merck Sharp + Dohme B.v.. Active years: 2013-2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013-2014
Title: Innovations by Marcus Antonius Bernardus Kruft
Introduction
Marcus Antonius Bernardus Kruft is a notable inventor based in Oss, Netherlands. He has made significant contributions to the field of drug delivery systems, holding 2 patents that showcase his innovative approach to healthcare solutions.
Latest Patents
Kruft's latest patents include a drug delivery system based on polyethylene vinylacetate copolymers. This system consists of one or more compartments and incorporates a progestogenic compound dissolved in a thermoplastic polyethylene vinylacetate copolymer. Additionally, he has developed a contraceptive kit or hormone-replacement therapy kit that utilizes this drug delivery system. Furthermore, he has disclosed a combination preparation that simultaneously provides contraception and treatment of a sexually transmitted disease, also based on this innovative drug delivery system.
Career Highlights
Throughout his career, Kruft has worked with prominent companies such as Merck Sharp & Dohme B.V. and has contributed to various projects that enhance drug delivery methods. His work has been instrumental in advancing the field of pharmaceuticals, particularly in the development of effective drug delivery systems.
Collaborations
Kruft has collaborated with notable individuals in his field, including Wouter De Graaff and Johannes Antonius Hendrikus Van Laarhoven. These collaborations have further enriched his work and contributed to the success of his inventions.
Conclusion
Marcus Antonius Bernardus Kruft is a distinguished inventor whose work in drug delivery systems has made a significant impact on healthcare. His innovative patents and collaborations reflect his commitment to advancing medical technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile